# Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines

> **NCT00984295** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 1913 (actual)

## Conditions studied

- Measles
- Mumps
- Rubella
- Varicella

## Interventions

- **BIOLOGICAL:** Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live
- **BIOLOGICAL:** Comparator: Tripedia
- **BIOLOGICAL:** Comparator: Comvax
- **BIOLOGICAL:** Comparator: Varivax
- **BIOLOGICAL:** Comparator: M-M-R II

## Key facts

- **NCT ID:** NCT00984295
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2001-10
- **Final completion:** 2001-12
- **Target enrollment:** 1913 (ACTUAL)
- **Last updated:** 2015-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00984295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00984295, "Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00984295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*